SYKSTRYKER CORP
Surgical & Medical Instruments & Apparatus
- Revenue
- $25.1B
- 11% YoY
- Operating margin
- 19.5%
- 19% YoY
- EBITDA
- $6.5B
- 26% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 1.8×
- $11.7B net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear155% of net incomeCash flow under 80% of net income
- Dilutive SBCClear1% of revenueOver 10% of revenue
- Payouts exceed cash flowClear25% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyFired41% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $17.1B | $18.4B | $20.5B | $22.6B | $25.1B | 11% |
| Operating income | $2.6B | $2.8B | $3.9B | $3.7B | $4.9B | 33% |
| Net income | $2.0B | $2.4B | $3.2B | $3.0B | $3.2B | 8.5% |
| Operating cash flow | $3.3B | $2.6B | $3.7B | $4.2B | $5.0B | 19% |
| Capex | $525M | $588M | $575M | $755M | $761M | 0.8% |
| Stock-based comp | $171M | $168M | $205M | $229M | $243M | 6.1% |
| Buybacks | $0 | — | — | — | — | |
| Dividends | $950M | $1.1B | $1.1B | $1.2B | $1.3B | 5.3% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
No pay-versus-performance disclosure yet.